2-(2-Bromo-4-fluorophenyl)-1,3-dioxolane, 95+%, 1g

(2E)-1-(2-methoxyphenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 10g

[S(R)]-N-[(1R)-1-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]-2,2-dimethylpropyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

2-Bromofluorene, 97.0%, 25g

methyl 5-(methoxymethyl)-1H-pyrazole-4-carboxylate, 98%, 1g

Ethyl 2-((2,4-difluorophenyl)amino)-2-oxoacetate, 95%, 250mg

Ethyl 1,3-dimethyl-4-nitro-1H-pyrazole-5-carboxylate, 95.0%, 5g

5,6-Dichloro-N-(2,4-dimethoxybenzyl)-N-(5-fluorothiazol-2-yl)pyridine-3-sulfonamide, 98%, 100mg

5-Methyl-4-nitropyridin-2(1H)-one, 95%, 5g

3,3-DIFLUOROPROPANOIC ACID, 95%, 10g

(S,S'')-2,2''-Bis[(S)-4-isopropyloxazolin-2-yl]-1,1''-biferrocene>98.0%(T)500mg

4-[(6-chloro-3-pyridinyl)methyl]morpholine, 95.0%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(p-tolyl)propanoic acid, 95.0%, 250mg